L
Lineage Cell Therapeutics Inc
AMEX:LCTX
Lineage Cell Therapeutics Inc
AMEX:LCTX
Price:
1.3
USD
-1.52%
Market Cap:
$323.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lineage Cell Therapeutics Inc
AMEX:LCTX
|
US |
|
R
|
RWE AG
MIL:RWE
|
DE |
|
M
|
Masimo Corp
LSE:0JZ2
|
US |
|
B
|
Bank Negara Indonesia (Persero) Tbk PT
XMUN:BKE1
|
ID |
|
C
|
China Southern Airlines Co Ltd
F:ZNH
|
CN |
|
C
|
Currys PLC
SWB:CWB
|
UK |
|
R
|
RPC Inc
XBER:RLD
|
US |
|
G
|
General Dynamics Corp
XBER:GDX
|
US |
|
B
|
Bristol-Myers Squibb Co
LSE:0R1F
|
US |
Multiples-Based Value
The Multiples-Based Value for Lineage Cell Therapeutics Inc (LCTX) under the Base Case is hidden USD. Compared with the current market price of 1.3 USD, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LCTX Multiples-Based Value
LOCKED
